nodes	percent_of_prediction	percent_of_DWPC	metapath
Clodronate—PTGS2—obesity	0.39	1	CbGaD
Clodronate—SLC25A6—hindbrain—obesity	0.0126	0.0821	CbGeAlD
Clodronate—Stomach ache—Phendimetrazine—obesity	0.0114	0.0613	CcSEcCtD
Clodronate—PTGS2—ovarian follicle—obesity	0.00951	0.0622	CbGeAlD
Clodronate—Digestion impaired—Methamphetamine—obesity	0.00828	0.0444	CcSEcCtD
Clodronate—SLC25A6—islet of Langerhans—obesity	0.00812	0.0531	CbGeAlD
Clodronate—Digestion impaired—Benzphetamine—obesity	0.00799	0.0428	CcSEcCtD
Clodronate—SLC25A6—respiratory system—obesity	0.00767	0.0501	CbGeAlD
Clodronate—SLC25A5—islet of Langerhans—obesity	0.00706	0.0462	CbGeAlD
Clodronate—SLC25A5—respiratory system—obesity	0.00667	0.0436	CbGeAlD
Clodronate—Digestion impaired—Phentermine—obesity	0.00595	0.0319	CcSEcCtD
Clodronate—SLC25A6—cardiovascular system—obesity	0.00587	0.0384	CbGeAlD
Clodronate—SLC25A5—adrenal cortex—obesity	0.0056	0.0366	CbGeAlD
Clodronate—SLC25A6—adipose tissue—obesity	0.00518	0.0339	CbGeAlD
Clodronate—Digestion impaired—Diethylpropion—obesity	0.00518	0.0277	CcSEcCtD
Clodronate—SLC25A5—cardiovascular system—obesity	0.00511	0.0334	CbGeAlD
Clodronate—SLC25A6—digestive system—obesity	0.00488	0.0319	CbGeAlD
Clodronate—SLC25A4—cardiovascular system—obesity	0.00479	0.0313	CbGeAlD
Clodronate—SLC25A6—adrenal gland—obesity	0.00465	0.0304	CbGeAlD
Clodronate—SLC25A5—pituitary gland—obesity	0.00452	0.0296	CbGeAlD
Clodronate—SLC25A5—adipose tissue—obesity	0.00451	0.0295	CbGeAlD
Clodronate—SLC25A5—digestive system—obesity	0.00424	0.0277	CbGeAlD
Clodronate—SLC25A4—pituitary gland—obesity	0.00424	0.0277	CbGeAlD
Clodronate—SLC25A4—adipose tissue—obesity	0.00422	0.0276	CbGeAlD
Clodronate—Hepatocellular injury—Phenylpropanolamine—obesity	0.00416	0.0223	CcSEcCtD
Clodronate—SLC25A5—adrenal gland—obesity	0.00404	0.0264	CbGeAlD
Clodronate—SLC25A6—endocrine gland—obesity	0.00403	0.0263	CbGeAlD
Clodronate—SLC25A4—digestive system—obesity	0.00397	0.026	CbGeAlD
Clodronate—SLC25A4—adrenal gland—obesity	0.00379	0.0248	CbGeAlD
Clodronate—SLC25A6—liver—obesity	0.00363	0.0238	CbGeAlD
Clodronate—SLC25A5—endocrine gland—obesity	0.0035	0.0229	CbGeAlD
Clodronate—SLC25A4—endocrine gland—obesity	0.00328	0.0215	CbGeAlD
Clodronate—Abdominal pain upper—Phendimetrazine—obesity	0.00323	0.0173	CcSEcCtD
Clodronate—SLC25A5—liver—obesity	0.00316	0.0207	CbGeAlD
Clodronate—Gastrointestinal symptom NOS—Orlistat—obesity	0.00309	0.0166	CcSEcCtD
Clodronate—SLC25A4—Phenelzine—Phenylpropanolamine—obesity	0.00307	0.383	CbGdCrCtD
Clodronate—SLC25A4—liver—obesity	0.00296	0.0194	CbGeAlD
Clodronate—Cardiac failure—Phentermine—obesity	0.00296	0.0159	CcSEcCtD
Clodronate—SLC25A4—Phenelzine—Phentermine—obesity	0.00261	0.326	CbGdCrCtD
Clodronate—Renal impairment—Cimetidine—obesity	0.00251	0.0135	CcSEcCtD
Clodronate—SLC25A4—Phenelzine—Methamphetamine—obesity	0.00232	0.291	CbGdCrCtD
Clodronate—Digestion impaired—Bupropion—obesity	0.00229	0.0123	CcSEcCtD
Clodronate—Blood creatinine increased—Cimetidine—obesity	0.00224	0.012	CcSEcCtD
Clodronate—Neoplasm malignant—Sibutramine—obesity	0.00206	0.011	CcSEcCtD
Clodronate—PTGS2—gall bladder—obesity	0.00203	0.0133	CbGeAlD
Clodronate—Pneumonia—Cimetidine—obesity	0.00185	0.00993	CcSEcCtD
Clodronate—Creatinine increased—Sibutramine—obesity	0.00185	0.0099	CcSEcCtD
Clodronate—Anorexia—Benzphetamine—obesity	0.00182	0.00973	CcSEcCtD
Clodronate—Renal failure—Cimetidine—obesity	0.00181	0.0097	CcSEcCtD
Clodronate—Dyspepsia—Methamphetamine—obesity	0.00174	0.00932	CcSEcCtD
Clodronate—Gastrointestinal disorder—Methamphetamine—obesity	0.00171	0.00914	CcSEcCtD
Clodronate—Dyspepsia—Benzphetamine—obesity	0.00168	0.00899	CcSEcCtD
Clodronate—Decreased appetite—Benzphetamine—obesity	0.00166	0.00887	CcSEcCtD
Clodronate—Anorexia—Phendimetrazine—obesity	0.00166	0.00887	CcSEcCtD
Clodronate—Gastrointestinal disorder—Benzphetamine—obesity	0.00164	0.00881	CcSEcCtD
Clodronate—Urticaria—Methamphetamine—obesity	0.00157	0.00841	CcSEcCtD
Clodronate—Hepatocellular injury—Bupropion—obesity	0.00153	0.00822	CcSEcCtD
Clodronate—Urticaria—Benzphetamine—obesity	0.00151	0.00811	CcSEcCtD
Clodronate—Decreased appetite—Phendimetrazine—obesity	0.00151	0.00809	CcSEcCtD
Clodronate—Wheezing—Bupropion—obesity	0.00149	0.00798	CcSEcCtD
Clodronate—Hepatic function abnormal—Sibutramine—obesity	0.00146	0.00783	CcSEcCtD
Clodronate—Abdominal pain—Phendimetrazine—obesity	0.00137	0.00736	CcSEcCtD
Clodronate—Diarrhoea—Methamphetamine—obesity	0.00135	0.00724	CcSEcCtD
Clodronate—Renal impairment—Sibutramine—obesity	0.00134	0.00719	CcSEcCtD
Clodronate—PTGS2—islet of Langerhans—obesity	0.00133	0.0087	CbGeAlD
Clodronate—Dyspnoea—Phenylpropanolamine—obesity	0.00132	0.00709	CcSEcCtD
Clodronate—Diarrhoea—Benzphetamine—obesity	0.0013	0.00698	CcSEcCtD
Clodronate—Hepatic function abnormal—Bupropion—obesity	0.00127	0.00683	CcSEcCtD
Clodronate—PTGS2—respiratory system—obesity	0.00126	0.00821	CbGeAlD
Clodronate—Dyspepsia—Phentermine—obesity	0.00125	0.00669	CcSEcCtD
Clodronate—Gastrointestinal disorder—Phentermine—obesity	0.00123	0.00657	CcSEcCtD
Clodronate—Abdominal pain upper—Orlistat—obesity	0.00121	0.00646	CcSEcCtD
Clodronate—Blood creatinine increased—Sibutramine—obesity	0.0012	0.00641	CcSEcCtD
Clodronate—Diarrhoea—Phendimetrazine—obesity	0.00119	0.00637	CcSEcCtD
Clodronate—Dehydration—Sibutramine—obesity	0.00119	0.00636	CcSEcCtD
Clodronate—Nausea—Benzphetamine—obesity	0.00113	0.00606	CcSEcCtD
Clodronate—Urticaria—Phentermine—obesity	0.00113	0.00604	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Sibutramine—obesity	0.00113	0.00604	CcSEcCtD
Clodronate—Abdominal pain—Phentermine—obesity	0.00112	0.00601	CcSEcCtD
Clodronate—Bronchospasm—Orlistat—obesity	0.00112	0.00601	CcSEcCtD
Clodronate—Dysphagia—Sibutramine—obesity	0.0011	0.00592	CcSEcCtD
Clodronate—Dyspnoea—Diethylpropion—obesity	0.0011	0.0059	CcSEcCtD
Clodronate—Dyspepsia—Diethylpropion—obesity	0.00109	0.00582	CcSEcCtD
Clodronate—Hypocalcaemia—Topiramate—obesity	0.00107	0.00572	CcSEcCtD
Clodronate—Gastrointestinal disorder—Diethylpropion—obesity	0.00107	0.00571	CcSEcCtD
Clodronate—Oliguria—Topiramate—obesity	0.00106	0.00568	CcSEcCtD
Clodronate—PTGS2—adrenal cortex—obesity	0.00105	0.00689	CbGeAlD
Clodronate—Dehydration—Bupropion—obesity	0.00104	0.00555	CcSEcCtD
Clodronate—Nausea—Phendimetrazine—obesity	0.00103	0.00553	CcSEcCtD
Clodronate—Creatinine increased—Topiramate—obesity	0.00103	0.0055	CcSEcCtD
Clodronate—Abdominal pain upper—Bupropion—obesity	0.00102	0.00545	CcSEcCtD
Clodronate—Renal failure—Orlistat—obesity	0.001	0.00536	CcSEcCtD
Clodronate—Pneumonia—Sibutramine—obesity	0.00099	0.0053	CcSEcCtD
Clodronate—Urticaria—Diethylpropion—obesity	0.000981	0.00526	CcSEcCtD
Clodronate—Diarrhoea—Phentermine—obesity	0.000971	0.0052	CcSEcCtD
Clodronate—Renal failure—Sibutramine—obesity	0.000968	0.00518	CcSEcCtD
Clodronate—Dysphagia—Bupropion—obesity	0.000962	0.00516	CcSEcCtD
Clodronate—PTGS2—cardiovascular system—obesity	0.000962	0.00629	CbGeAlD
Clodronate—Bronchospasm—Bupropion—obesity	0.000947	0.00507	CcSEcCtD
Clodronate—Vomiting—Phenylpropanolamine—obesity	0.000943	0.00505	CcSEcCtD
Clodronate—Rash—Phenylpropanolamine—obesity	0.000935	0.00501	CcSEcCtD
Clodronate—Dermatitis—Phenylpropanolamine—obesity	0.000934	0.00501	CcSEcCtD
Clodronate—Pharyngitis—Orlistat—obesity	0.000906	0.00486	CcSEcCtD
Clodronate—Vomiting—Phentermine—obesity	0.000903	0.00484	CcSEcCtD
Clodronate—Urinary tract disorder—Orlistat—obesity	0.000902	0.00483	CcSEcCtD
Clodronate—Urethral disorder—Orlistat—obesity	0.000895	0.0048	CcSEcCtD
Clodronate—Rash—Phentermine—obesity	0.000895	0.0048	CcSEcCtD
Clodronate—Dermatitis—Phentermine—obesity	0.000894	0.00479	CcSEcCtD
Clodronate—Nausea—Phenylpropanolamine—obesity	0.000881	0.00472	CcSEcCtD
Clodronate—Pharyngitis—Sibutramine—obesity	0.000877	0.0047	CcSEcCtD
Clodronate—Pneumonia—Bupropion—obesity	0.000863	0.00462	CcSEcCtD
Clodronate—PTGS2—pituitary gland—obesity	0.000852	0.00557	CbGeAlD
Clodronate—PTGS2—adipose tissue—obesity	0.000848	0.00555	CbGeAlD
Clodronate—Diarrhoea—Diethylpropion—obesity	0.000845	0.00453	CcSEcCtD
Clodronate—Nausea—Phentermine—obesity	0.000843	0.00452	CcSEcCtD
Clodronate—Mediastinal disorder—Orlistat—obesity	0.000823	0.00441	CcSEcCtD
Clodronate—Diarrhoea—Cimetidine—obesity	0.000804	0.00431	CcSEcCtD
Clodronate—PTGS2—digestive system—obesity	0.000799	0.00522	CbGeAlD
Clodronate—Vomiting—Diethylpropion—obesity	0.000785	0.00421	CcSEcCtD
Clodronate—Rash—Diethylpropion—obesity	0.000779	0.00417	CcSEcCtD
Clodronate—Dermatitis—Diethylpropion—obesity	0.000778	0.00417	CcSEcCtD
Clodronate—Pharyngitis—Bupropion—obesity	0.000765	0.0041	CcSEcCtD
Clodronate—PTGS2—adrenal gland—obesity	0.000761	0.00498	CbGeAlD
Clodronate—Urinary tract disorder—Bupropion—obesity	0.000761	0.00408	CcSEcCtD
Clodronate—Connective tissue disorder—Bupropion—obesity	0.000757	0.00406	CcSEcCtD
Clodronate—Urethral disorder—Bupropion—obesity	0.000755	0.00405	CcSEcCtD
Clodronate—Vomiting—Cimetidine—obesity	0.000747	0.004	CcSEcCtD
Clodronate—Rash—Cimetidine—obesity	0.000741	0.00397	CcSEcCtD
Clodronate—Dermatitis—Cimetidine—obesity	0.00074	0.00397	CcSEcCtD
Clodronate—Nausea—Diethylpropion—obesity	0.000733	0.00393	CcSEcCtD
Clodronate—Angioedema—Orlistat—obesity	0.000726	0.00389	CcSEcCtD
Clodronate—Anaemia—Sibutramine—obesity	0.000711	0.00381	CcSEcCtD
Clodronate—Angioedema—Sibutramine—obesity	0.000703	0.00377	CcSEcCtD
Clodronate—Nausea—Cimetidine—obesity	0.000698	0.00374	CcSEcCtD
Clodronate—Mediastinal disorder—Bupropion—obesity	0.000694	0.00372	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000672	0.0036	CcSEcCtD
Clodronate—Blood creatinine increased—Topiramate—obesity	0.000665	0.00356	CcSEcCtD
Clodronate—PTGS2—endocrine gland—obesity	0.00066	0.00432	CbGeAlD
Clodronate—Dehydration—Topiramate—obesity	0.00066	0.00354	CcSEcCtD
Clodronate—Abdominal pain upper—Topiramate—obesity	0.000648	0.00347	CcSEcCtD
Clodronate—Infection—Orlistat—obesity	0.000644	0.00345	CcSEcCtD
Clodronate—Skin disorder—Orlistat—obesity	0.00063	0.00338	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Topiramate—obesity	0.000626	0.00335	CcSEcCtD
Clodronate—Infection—Sibutramine—obesity	0.000624	0.00334	CcSEcCtD
Clodronate—Anaemia—Bupropion—obesity	0.00062	0.00332	CcSEcCtD
Clodronate—Dysphagia—Topiramate—obesity	0.000613	0.00329	CcSEcCtD
Clodronate—Angioedema—Bupropion—obesity	0.000613	0.00328	CcSEcCtD
Clodronate—Skin disorder—Sibutramine—obesity	0.00061	0.00327	CcSEcCtD
Clodronate—Anorexia—Sibutramine—obesity	0.000598	0.00321	CcSEcCtD
Clodronate—PTGS2—liver—obesity	0.000595	0.00389	CbGeAlD
Clodronate—Dyspepsia—Orlistat—obesity	0.000571	0.00306	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000567	0.00304	CcSEcCtD
Clodronate—Decreased appetite—Orlistat—obesity	0.000564	0.00302	CcSEcCtD
Clodronate—Gastrointestinal disorder—Orlistat—obesity	0.00056	0.003	CcSEcCtD
Clodronate—Dyspnoea—Sibutramine—obesity	0.00056	0.003	CcSEcCtD
Clodronate—Dyspepsia—Sibutramine—obesity	0.000553	0.00296	CcSEcCtD
Clodronate—Pneumonia—Topiramate—obesity	0.00055	0.00295	CcSEcCtD
Clodronate—Decreased appetite—Sibutramine—obesity	0.000546	0.00292	CcSEcCtD
Clodronate—Infection—Bupropion—obesity	0.000544	0.00291	CcSEcCtD
Clodronate—Gastrointestinal disorder—Sibutramine—obesity	0.000542	0.0029	CcSEcCtD
Clodronate—Renal failure—Topiramate—obesity	0.000537	0.00288	CcSEcCtD
Clodronate—Skin disorder—Bupropion—obesity	0.000532	0.00285	CcSEcCtD
Clodronate—Anorexia—Bupropion—obesity	0.000522	0.0028	CcSEcCtD
Clodronate—Urticaria—Orlistat—obesity	0.000515	0.00276	CcSEcCtD
Clodronate—Abdominal pain—Orlistat—obesity	0.000513	0.00275	CcSEcCtD
Clodronate—Urticaria—Sibutramine—obesity	0.000499	0.00267	CcSEcCtD
Clodronate—Abdominal pain—Sibutramine—obesity	0.000496	0.00266	CcSEcCtD
Clodronate—Dyspnoea—Bupropion—obesity	0.000488	0.00261	CcSEcCtD
Clodronate—Pharyngitis—Topiramate—obesity	0.000487	0.00261	CcSEcCtD
Clodronate—Urinary tract disorder—Topiramate—obesity	0.000485	0.0026	CcSEcCtD
Clodronate—Connective tissue disorder—Topiramate—obesity	0.000482	0.00258	CcSEcCtD
Clodronate—Dyspepsia—Bupropion—obesity	0.000482	0.00258	CcSEcCtD
Clodronate—Urethral disorder—Topiramate—obesity	0.000481	0.00258	CcSEcCtD
Clodronate—Decreased appetite—Bupropion—obesity	0.000476	0.00255	CcSEcCtD
Clodronate—Gastrointestinal disorder—Bupropion—obesity	0.000473	0.00253	CcSEcCtD
Clodronate—Pruritus—Orlistat—obesity	0.000459	0.00246	CcSEcCtD
Clodronate—Pruritus—Sibutramine—obesity	0.000444	0.00238	CcSEcCtD
Clodronate—Diarrhoea—Orlistat—obesity	0.000444	0.00238	CcSEcCtD
Clodronate—Mediastinal disorder—Topiramate—obesity	0.000442	0.00237	CcSEcCtD
Clodronate—Urticaria—Bupropion—obesity	0.000435	0.00233	CcSEcCtD
Clodronate—Abdominal pain—Bupropion—obesity	0.000433	0.00232	CcSEcCtD
Clodronate—Diarrhoea—Sibutramine—obesity	0.00043	0.0023	CcSEcCtD
Clodronate—Vomiting—Orlistat—obesity	0.000412	0.00221	CcSEcCtD
Clodronate—Rash—Orlistat—obesity	0.000409	0.00219	CcSEcCtD
Clodronate—Dermatitis—Orlistat—obesity	0.000409	0.00219	CcSEcCtD
Clodronate—Vomiting—Sibutramine—obesity	0.000399	0.00214	CcSEcCtD
Clodronate—Rash—Sibutramine—obesity	0.000396	0.00212	CcSEcCtD
Clodronate—Dermatitis—Sibutramine—obesity	0.000395	0.00212	CcSEcCtD
Clodronate—Anaemia—Topiramate—obesity	0.000395	0.00212	CcSEcCtD
Clodronate—Pruritus—Bupropion—obesity	0.000387	0.00207	CcSEcCtD
Clodronate—Nausea—Orlistat—obesity	0.000385	0.00206	CcSEcCtD
Clodronate—Diarrhoea—Bupropion—obesity	0.000374	0.00201	CcSEcCtD
Clodronate—Nausea—Sibutramine—obesity	0.000373	0.002	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000361	0.00194	CcSEcCtD
Clodronate—Vomiting—Bupropion—obesity	0.000348	0.00186	CcSEcCtD
Clodronate—Infection—Topiramate—obesity	0.000346	0.00186	CcSEcCtD
Clodronate—Rash—Bupropion—obesity	0.000345	0.00185	CcSEcCtD
Clodronate—Dermatitis—Bupropion—obesity	0.000345	0.00185	CcSEcCtD
Clodronate—Skin disorder—Topiramate—obesity	0.000339	0.00181	CcSEcCtD
Clodronate—Anorexia—Topiramate—obesity	0.000332	0.00178	CcSEcCtD
Clodronate—Nausea—Bupropion—obesity	0.000325	0.00174	CcSEcCtD
Clodronate—Dyspnoea—Topiramate—obesity	0.000311	0.00167	CcSEcCtD
Clodronate—Dyspepsia—Topiramate—obesity	0.000307	0.00164	CcSEcCtD
Clodronate—Decreased appetite—Topiramate—obesity	0.000303	0.00162	CcSEcCtD
Clodronate—Gastrointestinal disorder—Topiramate—obesity	0.000301	0.00161	CcSEcCtD
Clodronate—Urticaria—Topiramate—obesity	0.000277	0.00148	CcSEcCtD
Clodronate—Abdominal pain—Topiramate—obesity	0.000276	0.00148	CcSEcCtD
Clodronate—Pruritus—Topiramate—obesity	0.000247	0.00132	CcSEcCtD
Clodronate—Diarrhoea—Topiramate—obesity	0.000239	0.00128	CcSEcCtD
Clodronate—Vomiting—Topiramate—obesity	0.000222	0.00119	CcSEcCtD
Clodronate—Rash—Topiramate—obesity	0.00022	0.00118	CcSEcCtD
Clodronate—Dermatitis—Topiramate—obesity	0.00022	0.00118	CcSEcCtD
Clodronate—Nausea—Topiramate—obesity	0.000207	0.00111	CcSEcCtD
Clodronate—PTGS2—Selenium Micronutrient Network—TNF—obesity	4.45e-05	0.000169	CbGpPWpGaD
Clodronate—SLC25A4—Disease—TYK2—obesity	4.44e-05	0.000169	CbGpPWpGaD
Clodronate—SLC25A5—Disease—MYC—obesity	4.41e-05	0.000168	CbGpPWpGaD
Clodronate—SLC25A5—Disease—TGFB1—obesity	4.4e-05	0.000168	CbGpPWpGaD
Clodronate—SLC25A4—Disease—RHOA—obesity	4.4e-05	0.000168	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PIK3CG—obesity	4.39e-05	0.000167	CbGpPWpGaD
Clodronate—PTGS2—Disease—ENPP1—obesity	4.39e-05	0.000167	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PIK3R1—obesity	4.35e-05	0.000166	CbGpPWpGaD
Clodronate—SLC25A4—Disease—NOS3—obesity	4.35e-05	0.000166	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CPT1A—obesity	4.33e-05	0.000165	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—DGAT2—obesity	4.32e-05	0.000165	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CS—obesity	4.32e-05	0.000165	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SUCLA2—obesity	4.32e-05	0.000165	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CPS1—obesity	4.32e-05	0.000165	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PIK3CB—obesity	4.31e-05	0.000164	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—obesity	4.28e-05	0.000163	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PTGS2—obesity	4.27e-05	0.000163	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PPARG—obesity	4.24e-05	0.000162	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—LIPC—obesity	4.22e-05	0.000161	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—APOC3—obesity	4.2e-05	0.00016	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—POMC—obesity	4.18e-05	0.000159	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—INS—obesity	4.16e-05	0.000158	CbGpPWpGaD
Clodronate—PTGS2—Disease—PFKFB3—obesity	4.13e-05	0.000157	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—LIPE—obesity	4.12e-05	0.000157	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—MUT—obesity	4.12e-05	0.000157	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CETP—obesity	4.08e-05	0.000155	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—SDC1—obesity	4.03e-05	0.000154	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MTOR—obesity	4.02e-05	0.000153	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PIK3CB—obesity	4.02e-05	0.000153	CbGpPWpGaD
Clodronate—PTGS2—Disease—ACACB—obesity	4.01e-05	0.000153	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PTGS2—obesity	3.98e-05	0.000152	CbGpPWpGaD
Clodronate—SLC25A6—Disease—STAT3—obesity	3.98e-05	0.000152	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—obesity	3.96e-05	0.000151	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYB5A—obesity	3.95e-05	0.000151	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—DGAT1—obesity	3.95e-05	0.000151	CbGpPWpGaD
Clodronate—PTGS2—Disease—PNLIP—obesity	3.91e-05	0.000149	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—obesity	3.9e-05	0.000149	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PIK3CD—obesity	3.86e-05	0.000147	CbGpPWpGaD
Clodronate—PTGS2—Disease—SDC3—obesity	3.82e-05	0.000145	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ALB—obesity	3.81e-05	0.000145	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ACLY—obesity	3.8e-05	0.000145	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—SREBF1—obesity	3.79e-05	0.000144	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—MYC—obesity	3.78e-05	0.000144	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TGFB1—obesity	3.77e-05	0.000144	CbGpPWpGaD
Clodronate—SLC25A5—Disease—PIK3CA—obesity	3.74e-05	0.000143	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—obesity	3.73e-05	0.000142	CbGpPWpGaD
Clodronate—PTGS2—Disease—HK2—obesity	3.73e-05	0.000142	CbGpPWpGaD
Clodronate—SLC25A6—Disease—MYC—obesity	3.7e-05	0.000141	CbGpPWpGaD
Clodronate—SLC25A6—Disease—TGFB1—obesity	3.69e-05	0.00014	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ENPP1—obesity	3.67e-05	0.00014	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ALOX12—obesity	3.67e-05	0.00014	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PIK3R1—obesity	3.65e-05	0.000139	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—NOS3—obesity	3.65e-05	0.000139	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—FASN—obesity	3.61e-05	0.000137	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—BCHE—obesity	3.59e-05	0.000137	CbGpPWpGaD
Clodronate—PTGS2—Selenium Micronutrient Network—IL6—obesity	3.59e-05	0.000137	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HMGCS1—obesity	3.56e-05	0.000136	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TNF—obesity	3.52e-05	0.000134	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PFKFB3—obesity	3.45e-05	0.000132	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ACADM—obesity	3.45e-05	0.000132	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SAT1—obesity	3.45e-05	0.000132	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ANGPTL4—obesity	3.45e-05	0.000132	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PLIN1—obesity	3.45e-05	0.000132	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PNPLA2—obesity	3.45e-05	0.000132	CbGpPWpGaD
Clodronate—PTGS2—Disease—HDAC8—obesity	3.44e-05	0.000131	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PIK3CB—obesity	3.37e-05	0.000128	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—OXCT1—obesity	3.36e-05	0.000128	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ACACB—obesity	3.36e-05	0.000128	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYTB—obesity	3.36e-05	0.000128	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PTGS2—obesity	3.33e-05	0.000127	CbGpPWpGaD
Clodronate—SLC25A5—Disease—IL6—obesity	3.32e-05	0.000126	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PNLIP—obesity	3.28e-05	0.000125	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SRD5A1—obesity	3.28e-05	0.000125	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SDC3—obesity	3.2e-05	0.000122	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—GGT1—obesity	3.18e-05	0.000121	CbGpPWpGaD
Clodronate—SLC25A6—Disease—PIK3CA—obesity	3.14e-05	0.00012	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PIK3CA—obesity	3.14e-05	0.000119	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—NCOA1—obesity	3.13e-05	0.000119	CbGpPWpGaD
Clodronate—PTGS2—Disease—PCK1—obesity	3.13e-05	0.000119	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP26B1—obesity	3.12e-05	0.000119	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—STS—obesity	3.12e-05	0.000119	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HK2—obesity	3.12e-05	0.000119	CbGpPWpGaD
Clodronate—SLC25A4—Disease—STAT3—obesity	3.11e-05	0.000118	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—obesity	3.09e-05	0.000118	CbGpPWpGaD
Clodronate—SLC25A5—Disease—AKT1—obesity	3.06e-05	0.000117	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PPARD—obesity	3.06e-05	0.000116	CbGpPWpGaD
Clodronate—PTGS2—Disease—ACP5—obesity	3.04e-05	0.000116	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—obesity	3.02e-05	0.000115	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SLC27A1—obesity	3e-05	0.000114	CbGpPWpGaD
Clodronate—PTGS2—Disease—G6PD—obesity	2.96e-05	0.000113	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—FABP4—obesity	2.94e-05	0.000112	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GLUL—obesity	2.94e-05	0.000112	CbGpPWpGaD
Clodronate—PTGS2—Disease—HK1—obesity	2.93e-05	0.000112	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MYC—obesity	2.89e-05	0.00011	CbGpPWpGaD
Clodronate—SLC25A4—Disease—TGFB1—obesity	2.88e-05	0.00011	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—IL6—obesity	2.84e-05	0.000108	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—obesity	2.83e-05	0.000108	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—UCP3—obesity	2.78e-05	0.000106	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—UCP2—obesity	2.78e-05	0.000106	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ECHS1—obesity	2.78e-05	0.000106	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HSD11B1—obesity	2.78e-05	0.000106	CbGpPWpGaD
Clodronate—SLC25A6—Disease—IL6—obesity	2.78e-05	0.000106	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ADH1B—obesity	2.74e-05	0.000104	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—APOB—obesity	2.7e-05	0.000103	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ACSL1—obesity	2.7e-05	0.000103	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PPARGC1B—obesity	2.7e-05	0.000103	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GPAM—obesity	2.7e-05	0.000103	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—PIK3CA—obesity	2.63e-05	0.0001	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HADH—obesity	2.62e-05	9.97e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—FADS1—obesity	2.62e-05	9.97e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PCK1—obesity	2.62e-05	9.97e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—LPL—obesity	2.58e-05	9.82e-05	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—obesity	2.57e-05	9.79e-05	CbGpPWpGaD
Clodronate—SLC25A6—Disease—AKT1—obesity	2.56e-05	9.77e-05	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—obesity	2.56e-05	9.76e-05	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—AKT1—obesity	2.56e-05	9.76e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ACP5—obesity	2.55e-05	9.7e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—RBP4—obesity	2.52e-05	9.6e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—GPX1—obesity	2.51e-05	9.58e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—G6PD—obesity	2.48e-05	9.46e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SREBF2—obesity	2.45e-05	9.34e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HK1—obesity	2.45e-05	9.34e-05	CbGpPWpGaD
Clodronate—SLC25A4—Disease—PIK3CA—obesity	2.45e-05	9.33e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CD36—obesity	2.45e-05	9.33e-05	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—obesity	2.39e-05	9.12e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PRKAR2B—obesity	2.39e-05	9.09e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CST3—obesity	2.39e-05	9.09e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—DCN—obesity	2.37e-05	9.03e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—LPA—obesity	2.37e-05	9.02e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—LPIN1—obesity	2.32e-05	8.83e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—NCF2—obesity	2.3e-05	8.78e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PPARA—obesity	2.28e-05	8.67e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—APOA5—obesity	2.27e-05	8.65e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—NAMPT—obesity	2.26e-05	8.61e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—GCK—obesity	2.25e-05	8.56e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—APOC3—obesity	2.23e-05	8.5e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—IAPP—obesity	2.23e-05	8.5e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—AGT—obesity	2.21e-05	8.4e-05	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—obesity	2.18e-05	8.31e-05	CbGpPWpGaD
Clodronate—SLC25A4—Disease—IL6—obesity	2.17e-05	8.26e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CLOCK—obesity	2.17e-05	8.25e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SLC22A1—obesity	2.17e-05	8.25e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—APOE—obesity	2.16e-05	8.23e-05	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—AKT1—obesity	2.15e-05	8.18e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—SDC1—obesity	2.14e-05	8.16e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—CAV1—obesity	2.14e-05	8.16e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—APOA1—obesity	2.14e-05	8.14e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SULT2A1—obesity	2.11e-05	8.04e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GLP1R—obesity	2.11e-05	8.04e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—AKR1C3—obesity	2.11e-05	8.03e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—DPYD—obesity	2.08e-05	7.91e-05	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PIK3CA—obesity	2.05e-05	7.82e-05	CbGpPWpGaD
Clodronate—SLC25A4—Disease—AKT1—obesity	2e-05	7.62e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PRKAR2B—obesity	2e-05	7.61e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—DCN—obesity	1.98e-05	7.56e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—GOT2—obesity	1.96e-05	7.47e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—obesity	1.95e-05	7.43e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CPT1A—obesity	1.93e-05	7.35e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—FASN—obesity	1.92e-05	7.31e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PARP1—obesity	1.91e-05	7.28e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NAMPT—obesity	1.89e-05	7.21e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PPARG—obesity	1.88e-05	7.17e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—LIPC—obesity	1.88e-05	7.17e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GCK—obesity	1.88e-05	7.17e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—APOC3—obesity	1.87e-05	7.12e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—POMC—obesity	1.86e-05	7.07e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CETP—obesity	1.81e-05	6.91e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—NOS1—obesity	1.8e-05	6.84e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SDC1—obesity	1.79e-05	6.84e-05	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—obesity	1.78e-05	6.79e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—TCF7L2—obesity	1.78e-05	6.77e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—AKR1C3—obesity	1.77e-05	6.73e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—SLC2A4—obesity	1.75e-05	6.65e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SCARB1—obesity	1.74e-05	6.62e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—obesity	1.71e-05	6.53e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—ALB—obesity	1.69e-05	6.45e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—GOT1—obesity	1.69e-05	6.44e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SREBF1—obesity	1.69e-05	6.43e-05	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—AKT1—obesity	1.68e-05	6.39e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PRL—obesity	1.67e-05	6.35e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GOT2—obesity	1.64e-05	6.25e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—obesity	1.62e-05	6.17e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—FASN—obesity	1.61e-05	6.12e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—BCHE—obesity	1.6e-05	6.09e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—FOXO3—obesity	1.59e-05	6.04e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP2E1—obesity	1.54e-05	5.88e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NQO1—obesity	1.53e-05	5.81e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—obesity	1.49e-05	5.69e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SLC2A4—obesity	1.46e-05	5.57e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GCG—obesity	1.46e-05	5.57e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYCS—obesity	1.44e-05	5.5e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—APOB—obesity	1.44e-05	5.47e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GGT1—obesity	1.42e-05	5.4e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GOT1—obesity	1.42e-05	5.4e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NCOA1—obesity	1.4e-05	5.32e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—STK11—obesity	1.38e-05	5.24e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CYP19A1—obesity	1.38e-05	5.24e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—LPL—obesity	1.37e-05	5.22e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—FOXO1—obesity	1.36e-05	5.18e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—COMT—obesity	1.28e-05	4.87e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PRKCD—obesity	1.26e-05	4.81e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PPARGC1A—obesity	1.26e-05	4.8e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GNB3—obesity	1.26e-05	4.8e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HMOX1—obesity	1.26e-05	4.78e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—MTHFR—obesity	1.23e-05	4.7e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GNAS—obesity	1.23e-05	4.68e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—APOB—obesity	1.2e-05	4.58e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—IRS2—obesity	1.17e-05	4.47e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—APOE—obesity	1.15e-05	4.38e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—LPL—obesity	1.15e-05	4.37e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—CAV1—obesity	1.14e-05	4.34e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—APOA1—obesity	1.14e-05	4.33e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GPX1—obesity	1.12e-05	4.27e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CD36—obesity	1.09e-05	4.16e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—BAD—obesity	1.07e-05	4.08e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—MTHFR—obesity	1.03e-05	3.94e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—IRS1—obesity	1.02e-05	3.9e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PPARA—obesity	1.01e-05	3.86e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—AGT—obesity	9.82e-06	3.74e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—INS—obesity	9.82e-06	3.74e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—APOE—obesity	9.62e-06	3.67e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—CAV1—obesity	9.53e-06	3.63e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—APOA1—obesity	9.51e-06	3.62e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—AKT2—obesity	9.49e-06	3.61e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PIK3CD—obesity	9.12e-06	3.47e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	9.11e-06	3.47e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—SERPINE1—obesity	9.02e-06	3.43e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—TYK2—obesity	8.77e-06	3.34e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—RHOA—obesity	8.7e-06	3.31e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PIK3CG—obesity	8.68e-06	3.31e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—NOS3—obesity	8.61e-06	3.28e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PIK3R1—obesity	8.61e-06	3.28e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PPARG—obesity	8.38e-06	3.19e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—POMC—obesity	8.27e-06	3.15e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—INS—obesity	8.22e-06	3.13e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—MTOR—obesity	7.95e-06	3.03e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PIK3CB—obesity	7.95e-06	3.03e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PIK3CD—obesity	7.63e-06	2.91e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ALB—obesity	7.54e-06	2.87e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PIK3R1—obesity	7.21e-06	2.75e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NOS3—obesity	7.21e-06	2.75e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PIK3CB—obesity	6.65e-06	2.53e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—STAT3—obesity	6.14e-06	2.34e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—MYC—obesity	5.71e-06	2.17e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—TGFB1—obesity	5.69e-06	2.17e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—PIK3CA—obesity	4.84e-06	1.85e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—IL6—obesity	4.29e-06	1.63e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—PIK3CA—obesity	4.06e-06	1.55e-05	CbGpPWpGaD
Clodronate—PTGS2—Disease—AKT1—obesity	3.96e-06	1.51e-05	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—AKT1—obesity	3.31e-06	1.26e-05	CbGpPWpGaD
